Revolution Medicines (RVMD, $37.28) was one of top quarterly gainers, jumping +3 to $37.28 per share. A.I.dvisor analyzed 914 stocks in the Biotechnology Industry over the last three months, and discovered that of them (5) charted an Uptrend while of them (4) trended down. A.I.dvisor found 261 similar cases when RVMD's price went up within three months. In out of those 261 cases, RVMD's price went down during the following month. Based on these historical data, A.I. thinks the odds of an Uptrend reversal for RVMD are
an oncology company, which focused on developing novel targeted therapies and engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment.